Frontiers in Molecular Biosciences, 2024 · DOI: 10.3389/fmolb.2024.1363838 · Published: April 29, 2024
Spinal cord injury leads to serious functional disorders, impacting patients and society. Traditional treatments are not very effective, as the injured spinal cord is difficult to repair. Dental pulp stem cells have neuro-regenerative potential, offering hope for spinal cord injury biotherapy.
DPSCs show promise as a cell-based therapy for SCI, warranting further research and clinical trials.
Understanding DPSCs' mechanisms can inform targeted therapies to promote spinal cord regeneration and functional recovery.
Combining DPSCs with biomaterials can enhance their neurogenic differentiation and therapeutic efficacy in SCI treatment.